For: | Zhang YQ, Li J, Qin Z, Li DM, Ye FZ, Bei SH, Zhang XH, Feng L. METTL5 promotes gastric cancer progression via sphingomyelin metabolism. World J Gastrointest Oncol 2024; 16(5): 1925-1946 [PMID: 38764837 DOI: 10.4251/wjgo.v16.i5.1925] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v16/i5/1925.htm |
Number | Citing Articles |
1 |
Yujin Dong, Wei Chang, Bei Lu, Yuanyuan Li, Yuanhua Liu. METTL5-mediated m6A modification of SLC7A11 promotes cervical cancer by inhibiting ferroptosis. The International Journal of Biochemistry & Cell Biology 2025; 186: 106822 doi: 10.1016/j.biocel.2025.106822
|
2 |
Jin-Juan Zhang, Chang Yuan, Sheng-Chun Dang. Targeting methyltransferase-like 5-mediated sphingomyelin metabolism: A novel therapeutic approach in gastric cancer. World Journal of Gastrointestinal Oncology 2024; 16(10): 4060-4063 doi: 10.4251/wjgo.v16.i10.4060
|
3 |
Wei Dai, Yuan-Qi Li, You Zhou. Clinical implications of the latest advances in gastrointestinal tumor research. World Journal of Gastrointestinal Oncology 2024; 16(10): 4055-4059 doi: 10.4251/wjgo.v16.i10.4055
|
4 |
Junyao Jiang, Fangmin Zhong, Zuomiao Xiao, Fangyi Yao, Jing Liu, Meiyong Li, Huan Zeng, Yuxiang Qiu, Jing Zhang, Haibin Zhang, Shuqi Li, Ting huang, Wenli Feng, Zhenglan Huang, Bo Huang, Xiaozhong Wang. METTL5 regulates SEPHS2-mediated selenoprotein synthesis to promote multiple myeloma survival and progression. Cell Death & Disease 2025; 16(1) doi: 10.1038/s41419-025-07904-6
|